BRD7 could inhibit NPC growth and enhance the cytotoxicity of CD8+ T lymphocytes through downregulating PD-L1 expression, thereby suppressing immune escape in NPC (Figure 7). The gene discussed is CD274; the disease is nasopharyngeal carcinoma.